MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements

MAPS Public Benefit Corporation has shown off phase 3 data it hopes will secure a landmark approval for MDMA in the U.S. next year. | MAPS Public Benefit Corporation has shown off phase 3 data it hopes will secure a landmark approval for MDMA in the U.S. next year. The second phase 3 success is…#mdma
Source: Reuters: Health - Category: Consumer Health News Source Type: news